Diligence memo · auto-generated · as of July 2, 2026

SnapMedTech, Inc.

SnapMedTech, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

SnapMedTech, Inc. operates in Hospitals and Physicians, based in ATLANTA.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

SnapMedTech, Inc. has raised $19M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $18M on 2021-08-20.

Most recent recorded round closed around 2021-08-20.

Valuation (modeled)modeled

Provath models SnapMedTech, Inc. at approximately $265M (range $44M–$821M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.79× the median modeled value of Series B Hospitals and Physicians companies in 2019–2021 (8 peers) — value vs value, same stage and era. Within the normal band (79% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 48 months.

Last raise 4.9 yr ago; this sector typically re-raises about every 12 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 13.7× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 87% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 91% of those peers.

Closest niche peers: CareMount Health Solutions, LLC, Kandula Equity Holdings, LLC, Second Wave Delivery Systems, LLC, Mbmg Ultimate Holding, L.P., DSB Parent L.P..

Peoplefiled

10 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.